Owner: shah URL:www.stockdselse.blogspot.com Join Date: Fri, 01 Aug 2008 10:40:07 -0500 Rating:0 Site Description: stock mania Site statistics:Click here
Schering-Plough's Q2 income down 2008-07-24 07:14:00 Jul 23, 2008 ( Shah's finance Datamonitor via COMTEX) -- SGP Quote Chart News PowerRating -- Schering-Plough has posted a net income of $398 million for the second quarter of 2008, compared with $517 million for the same quarter in 2007. The company attributed the lower second quarter earnings to the acquisition of biotech group Organon BioSciences.The company posted net sales of $4.9 billion
SSL International says Q1 trading in line with its expectations 2008-07-24 07:08:00 LONDON, Jul 24, 2008 ( Shah's financial ) -- SLSLF Quote Chart News PowerRating -- SSL International
Plc. said its first quarter trading is in line with expectations with good underlying revenue growth, beneficial exchange rate movement and a strong balance sheet."Durex and Scholl, continue to make good progress, driving us towards our target of growing operating profit by at least 10 percent
All Funds are going under pressure on BD Stocks 2008-06-30 06:16:00 All kinds of Fund of DSE and CSE are going under pressure having notice from the two stock exchange that any Fund does not have facility to declare dividend for their share holders. In a press notice DSE and CSE said that there is no scope to declare any dividend by any Fund Company as there is no such evidence in international market. They also said that as all Funds
are not industry based or pro Read more:Stocks
MRK lost agreement of 200 with SGP 2008-06-30 06:09:00 30 June Merck & Co and Schering-Plough have decided to withdraw a New Drug Application for a combination tablet of the firms’ big-selling Claritin and Singulair, and are terminating their eight-year respiratory joint venture.It is not an overly-surprising decision, coming as it does a couple of months after the two companies received a not-approvable letter from the FDA for a proposed fixed
Pfizer agreed to settle litigation 2008-08-11 08:56:00 Pfizer Inc (PFE.N: Quote, Profile, Research, Stock Buzz) said it had agreed to settle litigation related to its cholesterol drug Lipitor with Canadian generic drug maker Apotex Inc. (Reporting by Shah Anaym Kabir). Read more:Pfizer
Mylan 3Q profit up 15 percent on generic sales 2008-10-31 04:01:00 Oct 30 - Mylan Inc. said Thursday its third-quarter profit
grew 15 percent due to sales from the Merck KGaA generic business, which it bought last year, and deferred revenue from the sale of a blood pressure drug.Net income rose to $172 million, or 45 cents a share, from $149.8 million, or 60 cents a share, a year earlier. Excluding one-time gains, Mylan said its profit was $105.4 million, or 23 c
Third-quarter Earning of Eli Lilly and Co. 2008-10-31 03:57:00 Oct 23, Eli Lilly
and Co. said an expected settlement of investigations into top-selling drug Zyprexa wiped out its third-quarter
profit, but the drugmaker's adjusted earnings still beat Wall Street expectations.Eli Lilly lost $465.6 million, or 43 cents per share. Last year it earned $926.3 million, or 85 cents per share, in the same quarter. Excluding charges that included almost $1.5 billion fo Read more:Earning
Shah added in his Portfolio: Merck & Co. Inc. (MRK) 2008-10-31 03:36:00 Shah added to his holdings in Merck
& Co. Inc. by 40.73%. The impact to his portfolio due to this purchase was 1.04%. His holdings were 22,371,200 shares as of 09/30/2008.Merck & Co. Inc. is a global research-driven pharmaceutical company dedicated to putting patients first. Established in 1891 Merck discovers develops manufactures and markets vaccines and medicines to address unmet medica Read more:Portfolio
Johnson & Johnson in 14 October reported a 30% jump in third-quarter profit 2008-10-17 05:41:00 Health care giant Johnson
& Johnson in 14 Octoberreported
a 30% jump in third
-quarterprofit
, beating Wall Street expectations, due to higher sales of consumer products and medical devices and a large restructuring charge a year ago.JNJ earned $3.31 billion or $1.17 per share in the quarter compared with $2.55 billion, or 88 cents per share, in the year-earlier period, when the company took r
Recommend Site To A Friend
